T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference? / Dominguez, Helena.

I: Atherosclerosis Supplements, 2005.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Dominguez, H 2005, 'T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?', Atherosclerosis Supplements.

APA

Dominguez, H. (2005). T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference? Atherosclerosis Supplements.

Vancouver

Dominguez H. T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference? Atherosclerosis Supplements. 2005.

Author

Dominguez, Helena. / T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?. I: Atherosclerosis Supplements. 2005.

Bibtex

@article{3aa8318c2e2a4021a261e432513025e8,
title = "T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?",
author = "Helena Dominguez",
year = "2005",
language = "Udefineret/Ukendt",
journal = "Atherosclerosis Plus",
issn = "2667-0909",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - T01-P-016 The insulin resistance syndrome and endothelial dysfunction—Does nateglinide make a difference?

AU - Dominguez, Helena

PY - 2005

Y1 - 2005

M3 - Tidsskriftartikel

JO - Atherosclerosis Plus

JF - Atherosclerosis Plus

SN - 2667-0909

ER -

ID: 303684789